4SC-203
CAS No. 895533-09-2
4SC-203( —— )
Catalog No. M28711 CAS No. 895533-09-2
4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 155 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 440 | In Stock |
|
| 50MG | 607 | In Stock |
|
| 100MG | 863 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4SC-203
-
NoteResearch use only, not for human use.
-
Brief Description4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
-
Description4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFLT
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number895533-09-2
-
Formula Weight1283.53
-
Molecular FormulaC66H74N16O8S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (194.47 mM)
-
SMILESCc(cc1)cc(NC(Nc2nc(ccc(Nc(c3c4)ncnc3cc(OCCCN3CCN(C)CC3)c4OC)c3)c3s2)=O)c1OCCc(cc1)cc(NC(Nc2nc(ccc(Nc(c3c4)ncnc3cc(OCCCN3CCN(C)CC3)c4OC)c3)c3s2)=O)c1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bae Young-Soo, et al. Extractives of the Wood of Black Locust and the Bark of Poplar as Decay-Resistant Hardwood Tree Species. The Journal of veterinary medical science. 2000; 28(3): 52-61.
molnova catalog
related products
-
HM43239 B
HM43239 is an orally active and selective FLT3 inhibitor with IC 50 s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively.
-
AKN-028
AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor ( IC 50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation.
-
BGB-102
BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.
Cart
sales@molnova.com